Strella Biotechnology develops sensor-based systems and analytics software to monitor produce freshness and shelf life.
Strella Biotechnology has raised $4.3M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Strella Biotechnology's investors include Beta Milouot, Google for Startups, Google Ventures, Dorm Room Fund, Creative Destruction Lab.
Strella Biotechnology is headquartered in Seattle, United States.
Strella Biotechnology develops sensor-based systems and analytics software to monitor produce freshness and shelf life.
Strella Biotechnology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Strella Biotechnology — Funding & Investors." VCBacked, October 23, 2026, https://www.vcbacked.co/company/strella-biotechnology. Accessed November 12, 2026.
VCBacked. (2026). Strella Biotechnology — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/strella-biotechnology
{{cite web |title=Strella Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/strella-biotechnology |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Strella Biotechnology? Request a listing update